# Guangdong Pharmaceutical University

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/guangdong-pharmaceutical-university/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 54 |
| Citations | 880,605 |
| City | Guangzhou |
| Country | CN |
| Description | Guangdong Pharmaceutical University is a research organisation in Guangzhou, CN. OpenAlex records 17,365 works and 880,605 citations for it. 8,076 researchers list it as their most recent affiliation. |
| Homepage | http://www.gdpu.edu.cn/ |
| OpenAlex ID | https://openalex.org/I190242452 |
| Researchers | 8,076 |
| ROR ID | https://ror.org/02vg7mz57 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q5613642 |
| Works | 17,365 |

## University papers

Showing 12 of 31.

- [Catastrophic Antiphospholipid Syndrome: Clinical and Laboratory Features of 50 Patients](https://scholariq.org/papers/catastrophic-antiphospholipid-syndrome-clinical-and-laboratory-features-of-50/)
- [Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study](https://scholariq.org/papers/gefitinib-versus-vinorelbine-plus-cisplatin-as-adjuvant-treatment-for-stage-ii/)
- [A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese](https://scholariq.org/papers/a-genome-wide-association-study-identifies-two-new-lung-cancer-susceptibility/)
- [Early versus delayed administration of norepinephrine in patients with septic shock](https://scholariq.org/papers/early-versus-delayed-administration-of-norepinephrine-in-patients-with-septic/)
- [Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer](https://scholariq.org/papers/genomic-landscape-survey-identifies-srsf1-as-a-key-oncodriver-in-small-cell-lung/)
- [Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial](https://scholariq.org/papers/gefitinib-versus-vinorelbine-plus-cisplatin-as-adjuvant-treatment-for-stage-ii-2/)
- [Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 <i>EGFR</i>-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study](https://scholariq.org/papers/erlotinib-versus-gemcitabine-plus-cisplatin-as-neoadjuvant-treatment-of-stage/)
- [Anti-diabetic polysaccharides from natural sources: A review](https://scholariq.org/papers/anti-diabetic-polysaccharides-from-natural-sources-a-review/)
- [Histopathological types of cardiac fibrosis in myocardial disease](https://scholariq.org/papers/histopathological-types-of-cardiac-fibrosis-in-myocardial-disease/)
- [Naturally derived anti-inflammatory compounds from Chinese medicinal plants](https://scholariq.org/papers/naturally-derived-anti-inflammatory-compounds-from-chinese-medicinal-plants/)
- [Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients](https://scholariq.org/papers/comprehensive-genomic-and-immunological-characterization-of-chinese-non-small/)
- [Hidden Blood Loss After Total Hip Arthroplasty](https://scholariq.org/papers/hidden-blood-loss-after-total-hip-arthroplasty/)

## University researchers

- [Qiuhong Wang](https://scholariq.org/researchers/qiuhong-wang/)
- [Xudong Liu](https://scholariq.org/researchers/xudong-liu/)

## University top topics

Showing 8 of 25.

- [Traditional Chinese Medicine Analysis](https://scholariq.org/topics/traditional-chinese-medicine-analysis/)
- [Natural product bioactivities and synthesis](https://scholariq.org/topics/natural-product-bioactivities-and-synthesis/)
- [Pharmacological Effects of Natural Compounds](https://scholariq.org/topics/pharmacological-effects-of-natural-compounds/)
- [Advanced biosensing and bioanalysis techniques](https://scholariq.org/topics/advanced-biosensing-and-bioanalysis-techniques/)
- [Nanoplatforms for cancer theranostics](https://scholariq.org/topics/nanoplatforms-for-cancer-theranostics/)
- [Phytochemistry and Biological Activities](https://scholariq.org/topics/phytochemistry-and-biological-activities/)
- [Catalytic C–H Functionalization Methods](https://scholariq.org/topics/catalytic-c-h-functionalization-methods/)
- [Metabolomics and Mass Spectrometry Studies](https://scholariq.org/topics/metabolomics-and-mass-spectrometry-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.